Home » Finance

FedEx (NYSE:FDX) PT Raised to $179.00

FedEx (NYSE:FDX) PT Raised to $179.00

FedEx (NYSE:FDX) had its price objective increased by Wells Fargo & Co from $153.00 to $179.00 in a report issued on Wednesday morning, BenzingaRatingsTable reports. They currently have an overweight rating on the shipping... 
FedEx (NYSE:FDX) PT Raised to $176.00 at Sanford C. Bernstein

FedEx (NYSE:FDX) PT Raised to $176.00 at Sanford C. Bernstein

FedEx (NYSE:FDX) had its price target hoisted by Sanford C. Bernstein from $147.00 to $176.00 in a research report sent to investors on Wednesday, Briefing.com Automated Import reports. The brokerage currently has a market perform... 
FedEx (NYSE:FDX) Given New $177.00 Price Target at BofA Securities

FedEx (NYSE:FDX) Given New $177.00 Price Target at BofA Securities

FedEx (NYSE:FDX) had its price target upped by BofA Securities from $160.00 to $177.00 in a research report report published on Wednesday, Briefing.com Automated Import reports. BofA Securities currently has a buy rating on... 
John Bean Technologies (NYSE:JBT) Upgraded to “Strong-Buy” by Zacks Investment Research

John Bean Technologies (NYSE:JBT) Upgraded to “Strong-Buy” by Zacks Investment Research

Zacks Investment Research upgraded shares of John Bean Technologies (NYSE:JBT) from a hold rating to a strong-buy rating in a research report sent to investors on Wednesday morning, Zacks.com reports. The firm currently has... 
G1 Therapeutics’ (GTHX) “Buy” Rating Reiterated at Needham & Company LLC

G1 Therapeutics’ (GTHX) “Buy” Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of G1 Therapeutics (NASDAQ:GTHX) in a report published on Wednesday, AnalystRatings.com reports. The brokerage currently has a $74.00 price target on the stock. Several... 
PACCAR (NASDAQ:PCAR) Price Target Increased to $80.00 by Analysts at JPMorgan Chase & Co.

PACCAR (NASDAQ:PCAR) Price Target Increased to $80.00 by Analysts at JPMorgan Chase & Co.

PACCAR (NASDAQ:PCAR) had its price objective hoisted by JPMorgan Chase & Co. from $77.00 to $80.00 in a research note published on Wednesday, The Fly reports. The firm currently has an overweight rating on the stock. PCAR... 
Dollar General Corp. Announces Quarterly Dividend of $0.36 (NYSE:DG)

Dollar General Corp. Announces Quarterly Dividend of $0.36 (NYSE:DG)

Dollar General Corp. (NYSE:DG) announced a quarterly dividend on Thursday, May 28th, Zacks reports. Stockholders of record on Tuesday, July 7th will be paid a dividend of 0.36 per share on Tuesday, July 21st. This represents... 
Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) Raises Dividend to $0.15 Per Share

Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) Raises Dividend to $0.15 Per Share

Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) declared a final dividend on Wednesday, July 1st, MarketIndexAU reports. Stockholders of record on Friday, July 17th will be paid a dividend of 0.145 per share on Friday, July... 
John Wiley & Sons Inc (NYSE:JW.B) to Issue Quarterly Dividend of $0.34

John Wiley & Sons Inc (NYSE:JW.B) to Issue Quarterly Dividend of $0.34

John Wiley & Sons Inc (NYSE:JW.B) declared a quarterly dividend on Monday, June 29th, Wall Street Journal reports. Shareholders of record on Tuesday, July 7th will be paid a dividend of 0.3425 per share on Wednesday, July... 
Aegion (NASDAQ:AEGN) Releases Q2 2020
IntraDay Earnings Guidance

Aegion (NASDAQ:AEGN) Releases Q2 2020 IntraDay Earnings Guidance

Aegion (NASDAQ:AEGN) updated its second quarter 2020 IntraDay earnings guidance on Thursday. The company provided earnings per share guidance of 0.20-0.30 for the period, compared to the Thomson Reuters consensus earnings per... 
Sangamo Therapeutics (NASDAQ:SGMO) Stock Rating Lowered by BidaskClub

Sangamo Therapeutics (NASDAQ:SGMO) Stock Rating Lowered by BidaskClub

BidaskClub lowered shares of Sangamo Therapeutics (NASDAQ:SGMO) from a hold rating to a sell rating in a research report report published on Wednesday, BidAskClub reports. Other research analysts have also recently issued research... 
360 Finance (NASDAQ:QFIN) Lowered to Sell at Zacks Investment Research

360 Finance (NASDAQ:QFIN) Lowered to Sell at Zacks Investment Research

Zacks Investment Research lowered shares of 360 Finance (NASDAQ:QFIN) from a hold rating to a sell rating in a research note released on Wednesday morning, Zacks.com reports. According to Zacks, “360 Finance Inc. offers... 
Rent-A-Center (NASDAQ:RCII) Upgraded at BidaskClub

Rent-A-Center (NASDAQ:RCII) Upgraded at BidaskClub

BidaskClub upgraded shares of Rent-A-Center (NASDAQ:RCII) from a hold rating to a buy rating in a research report released on Wednesday, BidAskClub reports. Other equities research analysts have also recently issued reports... 
TAL Education Group (NYSE:TAL) PT Raised to $75.00

TAL Education Group (NYSE:TAL) PT Raised to $75.00

TAL Education Group (NYSE:TAL) had its target price raised by Goldman Sachs Group from $64.00 to $75.00 in a report published on Wednesday morning, The Fly reports. Other research analysts have also recently issued research... 
Renasant (NASDAQ:RNST) Upgraded at Zacks Investment Research

Renasant (NASDAQ:RNST) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Renasant (NASDAQ:RNST) from a strong sell rating to a hold rating in a research note published on Wednesday morning, Zacks.com reports. According to Zacks, “Renasant Corporation... 
RLJ Lodging Trust (NYSE:RLJ) Upgraded to Hold by Zacks Investment Research

RLJ Lodging Trust (NYSE:RLJ) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of RLJ Lodging Trust (NYSE:RLJ) from a sell rating to a hold rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “RLJ Lodging Trust is a REIT focused... 
Realogy (NYSE:RLGY) Upgraded to Hold at Zacks Investment Research

Realogy (NYSE:RLGY) Upgraded to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Realogy (NYSE:RLGY) from a sell rating to a hold rating in a research note released on Wednesday morning, Zacks.com reports. According to Zacks, “Realogy Holdings Corp. is... 
Scholar Rock (NASDAQ:SRRK) Downgraded by BidaskClub to Hold

Scholar Rock (NASDAQ:SRRK) Downgraded by BidaskClub to Hold

BidaskClub lowered shares of Scholar Rock (NASDAQ:SRRK) from a buy rating to a hold rating in a report issued on Wednesday, BidAskClub reports. Several other equities research analysts have also recently issued reports on the... 
Snap (NYSE:SNAP) Price Target Increased to $25.00 by Analysts at Canaccord Genuity

Snap (NYSE:SNAP) Price Target Increased to $25.00 by Analysts at Canaccord Genuity

Snap (NYSE:SNAP) had its price objective hoisted by Canaccord Genuity from $15.00 to $25.00 in a research note published on Wednesday morning, Briefing.com Automated Import reports. The brokerage currently has a hold rating... 
Peloton (NASDAQ:PTON) Price Target Increased to $70.00 by Analysts at Canaccord Genuity

Peloton (NASDAQ:PTON) Price Target Increased to $70.00 by Analysts at Canaccord Genuity

Peloton (NASDAQ:PTON) had its price objective increased by Canaccord Genuity from $50.00 to $70.00 in a report published on Wednesday, Briefing.com Automated Import reports. They currently have a speculative buy rating on the... 
Zacks Investment Research Downgrades Avid Bioservices (NASDAQ:CDMO) to Hold

Zacks Investment Research Downgrades Avid Bioservices (NASDAQ:CDMO) to Hold

Zacks Investment Research cut shares of Avid Bioservices (NASDAQ:CDMO) from a buy rating to a hold rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Avid Bioservices,... 
Facebook (NASDAQ:FB) Price Target Raised to $275.00 at Canaccord Genuity

Facebook (NASDAQ:FB) Price Target Raised to $275.00 at Canaccord Genuity

Facebook (NASDAQ:FB) had its price target upped by Canaccord Genuity from $250.00 to $275.00 in a report released on Wednesday morning, Briefing.com Automated Import reports. The brokerage currently has a buy rating on the social... 
Churchill Downs (NASDAQ:CHDN) Upgraded to “Strong-Buy” by Zacks Investment Research

Churchill Downs (NASDAQ:CHDN) Upgraded to “Strong-Buy” by Zacks Investment Research

Zacks Investment Research upgraded shares of Churchill Downs (NASDAQ:CHDN) from a hold rating to a strong-buy rating in a research report sent to investors on Wednesday, Zacks.com reports. They currently have $153.00 price target... 
Churchill Downs (NASDAQ:CHDN) Given New $148.00 Price Target at JPMorgan Chase & Co.

Churchill Downs (NASDAQ:CHDN) Given New $148.00 Price Target at JPMorgan Chase & Co.

Churchill Downs (NASDAQ:CHDN) had its target price upped by JPMorgan Chase & Co. from $138.00 to $148.00 in a research note published on Wednesday, The Fly reports. They currently have an overweight rating on the stock. A... 
Canaccord Genuity Boosts Netflix (NASDAQ:NFLX) Price Target to $550.00

Canaccord Genuity Boosts Netflix (NASDAQ:NFLX) Price Target to $550.00

Netflix (NASDAQ:NFLX) had its target price upped by Canaccord Genuity from $500.00 to $550.00 in a report published on Wednesday, Briefing.com Automated Import reports. They currently have a buy rating on the Internet television... 
Deutsche Bank (NYSE:DB) Cut to Sell at Societe Generale

Deutsche Bank (NYSE:DB) Cut to Sell at Societe Generale

Societe Generale downgraded shares of Deutsche Bank (NYSE:DB) from a hold rating to a sell rating in a research note issued to investors on Wednesday morning, The Fly reports. Several other analysts have also weighed in on the... 
Concert Pharmaceuticals (NASDAQ:CNCE) Stock Rating Lowered by Zacks Investment Research

Concert Pharmaceuticals (NASDAQ:CNCE) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research cut shares of Concert Pharmaceuticals (NASDAQ:CNCE) from a buy rating to a hold rating in a report issued on Wednesday morning, Zacks.com reports. According to Zacks, “Concert Pharmaceuticals... 
JPMorgan Chase & Co. Raises Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $84.00

JPMorgan Chase & Co. Raises Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $84.00

Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price objective boosted by JPMorgan Chase & Co. from $76.00 to $84.00 in a research note released on Wednesday, The Fly reports. JPMorgan Chase & Co. currently has an... 
Zacks Investment Research Upgrades Performance Food Group (NYSE:PFGC) to Strong-Buy

Zacks Investment Research Upgrades Performance Food Group (NYSE:PFGC) to Strong-Buy

Zacks Investment Research upgraded shares of Performance Food Group (NYSE:PFGC) from a strong sell rating to a strong-buy rating in a research note released on Wednesday morning, Zacks.com reports. The firm currently has $34.00... 
Paramount Group (NYSE:PGRE) Stock Rating Lowered by Zacks Investment Research

Paramount Group (NYSE:PGRE) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research cut shares of Paramount Group (NYSE:PGRE) from a buy rating to a hold rating in a report issued on Wednesday morning, Zacks.com reports. According to Zacks, “Paramount Group, Inc. is a real estate...